LITTLE FALLS, N.J.--(BUSINESS WIRE)--CANTEL MEDICAL CORP. (NYSE:CMN) reported income from continuing operations of $1,939,000, or $0.12 per diluted share, on a 19% increase in sales to $60,005,000 for the first quarter ended October 31, 2007, inclusive of approximately $0.01 in severance expenses related to the relocation of Medivators’ BV operation to the U.S. and expenses related to recent acquisitions and $0.02 of stock-based compensation. This compares with income from continuing operations of $1,723,000, or $0.11 per diluted share, on sales of $50,484,000 for the first quarter ended October 31, 2006, including $0.01 of stock-based compensation expense.
